Scientists at the Gladstone Institute of Neurological Disease ( GIND ) and the University of California have found that complete or partial removal of an enzyme that regulates fatty acid levels improves cognitive deficits in a mouse model of Alzheimer's disease.
Funding for the new laboratory was
obtained through a $1.7-million grant
from the California Institute for Regenerative
Medicine (CIRM). CIRM wants
to expand the laboratory space available
for nonfederally funded research
into human embryonic stem (hES) cells.
On June 25, the Alzheimer’s
Association and the Gladstone
Institute of Neurological Disease
(GIND) cosponsored the second annual Bay
Area Alzheimer’s Symposium at Gladstone.
The event brought together leading
Alzheimer’s disease (AD) researchers from
Gladstone, UCSF, Stanford, the Buck
Institute, and other institutions.
The Pew Charitable Trusts and UCSF announced that Gladstone Institutes and UCSF researcher Anatol C. Kreitzer, PhD, is one of 20 exceptional researchers selected as 2008 Pew Scholars in the Biomedical Sciences.
